Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy

NCT03344640 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Tendinopathy

Interventions

DRUG: secukinumab
OTHER: Placebo

Sponsor

Novartis Pharmaceuticals